Publications by authors named "N Chiu"

The optical properties of the 1D nanograting chip have been explored based on computational and experimental studies. Dispersion curve analysis demonstrates cavity and surface plasmon modes in the 1D nanograting chips with periods of 400 nm and 800 nm. In this grating period range, the cut-off period is at a grating period of 644 nm under excitation with a wavelength of 670 nm.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is the most common pathogen for young children hospitalized with bronchiolitis and pneumonia. Most infections occur below 1 year of age. RSV is also a significant viral pathogen for adults with respiratory tract infection.

View Article and Find Full Text PDF

Vaccination has been an effective method to prevent and control diphtheria, tetanus, pertussis and polio diseases in infancy and adults for years. To maintain the protective effect, a DTaP-IPV vaccine, Tetraxim, was introduced into Taiwan's national immunization program for children at 5 years of age after primary series vaccination in infancy in October 2017 replacing a Tdap-IPV. To survey the safety of this vaccine, data between 01 October 2017 and 31 December 2020 from two surveillance systems, the Vaccine Adverse Events Reporting System (VAERS) and Vaccine Injury Compensation Program (VICP), were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • Electroconvulsive therapy (ECT) is an effective treatment for persistent psychiatric disorders, though post-ECT fever is rare and not widely reported.
  • A case study of a 27-year-old woman with bipolar disorder showed she experienced multiple fever episodes after ECT, with diagnostic tests indicating inflammation but no signs of infection or serious syndromes.
  • The findings suggest that the fever may be a benign inflammatory response to ECT, allowing for the continued use of ECT to achieve therapeutic benefits.
View Article and Find Full Text PDF

This case-control study spanned from July 2022 to September 2023, focusing on the pre-Omicron COVID-19 mRNA vaccine effectiveness against the Omicron variant in children without prior SARS-CoV-2 exposure. We reported that pre-Omicron COVID-19 mRNA vaccines significantly reduced Omicron-induced hospitalizations in infection-naïve Taiwanese children. Our study also highlighted the socioeconomic factors influencing COVID-19 vulnerability among the children population.

View Article and Find Full Text PDF